⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Official Title: Osteoporosis Prevention in Prostate Cancer Patients Receiving Androgen Ablation Therapy: A Phase III Randomized, Placebo-Controlled, Double-Blind Study

Study ID: NCT00043069

Study Description

Brief Summary: RATIONALE: Preventing bone loss in patients who are undergoing androgen ablation for prostate cancer may decrease the risk of fractures and may help patients live more comfortably. It is not yet known whether calcium is more effective with or without estrogen and/or risedronate in preventing osteoporosis. PURPOSE: Randomized phase III trial to compare the effectiveness of two forms of calcium with or without estrogen and/or risedronate in preventing osteoporosis in patients with prostate cancer who are receiving androgen ablation therapy.

Detailed Description: OBJECTIVES: * Compare the change in bone mineral density in patients with prostate cancer who are receiving androgen-ablation therapy treated with calcium and cholecalciferol with or without conjugated estrogens and with or without risedronate. * Compare the toxicity of these regimens in these patients. * Compare the changes in bone markers in patients treated with these regimens. * Compare the quality of life of patients treated with these regimens. * Compare hot flashes in patients treated with these regimens. OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are stratified according to duration of therapy with luteinizing hormone-releasing hormone agonists (no more than 30 days vs 31 to 150 days vs 151 to 365 days vs more than 365 days). Patients are randomized to 1 of 4 treatment arms. * Arm I: Patients receive oral calcium, oral cholecalciferol, oral risedronate placebo, and oral estrogen placebo daily. * Arm II: Patients receive oral calcium, oral cholecalciferol, oral risedronate, and oral estrogen placebo daily. * Arm III: Patients receive oral calcium, oral cholecalciferol, low-dose oral conjugated estrogens, and oral risedronate placebo daily. * Arm IV: Patients receive oral calcium, oral cholecalciferol, low-dose oral conjugated estrogens, and oral risedronate daily. Treatment in all arms continues for 2 years. Quality of life is assessed at baseline, monthly for 6 months, and then at 1 and 2 years. Bone mineral density is assessed at baseline, 6 months, and 1 and 2 years. PROJECTED ACCRUAL: A total of 282 patients (70 per treatment arm) will be accrued for this study within 14 months.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: MALE

Healthy Volunteers: No

Locations

CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States

Mayo Clinic - Jacksonville, Jacksonville, Florida, United States

Rush-Copley Cancer Care Center, Aurora, Illinois, United States

St. Joseph Medical Center, Bloomington, Illinois, United States

Graham Hospital, Canton, Illinois, United States

Memorial Hospital, Carthage, Illinois, United States

Eureka Hospital, Eureka, Illinois, United States

Galesburg Clinic, Galesburg, Illinois, United States

Galesburg Cottage Hospital, Galesburg, Illinois, United States

InterCommunity Cancer Center of Western Illinois, Galesburg, Illinois, United States

Mason District Hospital, Havana, Illinois, United States

Hopedale Medical Complex, Hopedale, Illinois, United States

Joliet Oncology Hematology Associates, Limited - West, Joliet, Illinois, United States

Kewanee Hospital, Kewanee, Illinois, United States

McDonough District Hospital, Macomb, Illinois, United States

BroMenn Regional Medical Center, Normal, Illinois, United States

Community Cancer Center, Normal, Illinois, United States

Community Hospital of Ottawa, Ottawa, Illinois, United States

Oncology Hematology Associates of Central Illinois - Ottawa, Ottawa, Illinois, United States

Cancer Treatment Center at Pekin Hospital, Pekin, Illinois, United States

Methodist Medical Center of Illinois, Peoria, Illinois, United States

Proctor Hospital, Peoria, Illinois, United States

CCOP - Illinois Oncology Research Association, Peoria, Illinois, United States

Oncology/Hematology Associates of Central Illinois, P.C., Peoria, Illinois, United States

OSF St. Francis Medical Center, Peoria, Illinois, United States

Illinois Valley Community Hospital, Peru, Illinois, United States

Perry Memorial Hospital, Princeton, Illinois, United States

St. Margaret's Hospital, Spring Valley, Illinois, United States

Valley Cancer Center, Spring Valley, Illinois, United States

Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States

CCOP - Carle Cancer Center, Urbana, Illinois, United States

Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States

McFarland Clinic, P.C., Ames, Iowa, United States

Saint Anthony Regional Hospital, Carroll, Iowa, United States

Alegent Health Mercy Hospital, Council Bluffs, Iowa, United States

Mercy Capitol Hospital, Des Moines, Iowa, United States

CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines, Iowa, United States

Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States

Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines, Iowa, United States

Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States

John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines, Iowa, United States

Mercy Cancer Center at Mercy Medical Center - North Iowa, Mason City, Iowa, United States

Alegent Health Community Memorial Hospital, Missouri Valley, Iowa, United States

Burgess Health Center, Onawa, Iowa, United States

Cancer Center at Ottumwa Regional Health Center, Ottumwa, Iowa, United States

Siouxland Regional Cancer Center, Sioux City, Iowa, United States

Siouxland Hematology-Oncology Associates, Sioux City, Iowa, United States

Mercy Medical Center - Sioux City, Sioux City, Iowa, United States

St. Luke's Regional Medical Center, Sioux City, Iowa, United States

Medical Oncology and Hematology Associates - West Des Moines, West Des Moines, Iowa, United States

Cancer Center of Kansas - Chanute, Chanute, Kansas, United States

Cancer Center of Kansas - Dodge City, Dodge City, Kansas, United States

Cancer Center of Kansas, P.A. - El Dorado, El Dorado, Kansas, United States

Cancer Center of Kansas - Kingman, Kingman, Kansas, United States

Southwest Medical Center, Liberal, Kansas, United States

Cancer Center of Kansas - Newton, Newton, Kansas, United States

Cancer Center of Kansas, P.A. - Parsons, Parsons, Kansas, United States

Pratt Cancer Center of Kansas, Pratt, Kansas, United States

Cancer Center of Kansas - Salina, Salina, Kansas, United States

Cancer Center of Kansas - Wellington, Wellington, Kansas, United States

Associates in Womens Health, Wichita, Kansas, United States

Cancer Center of Kansas, P.A., Wichita, Kansas, United States

Cancer Center of Kansas, P.A. - Wichita, Wichita, Kansas, United States

CCOP - Wichita, Wichita, Kansas, United States

Via Christi Cancer Center at Via Christi Regional Medical Center, Wichita, Kansas, United States

Cancer Center of Kansas - Winfield, Winfield, Kansas, United States

Brainerd Medical Center, Brainerd, Minnesota, United States

Fairview Ridges Hospital, Burnsville, Minnesota, United States

Mercy Hospital, Coon Rapids, Minnesota, United States

CCOP - Duluth, Duluth, Minnesota, United States

Miller-Dwan Medical Center, Duluth, Minnesota, United States

St. Mary's - Duluth Clinic Cancer Center, Duluth, Minnesota, United States

Fairview Southdale Hospital, Edina, Minnesota, United States

Mercy and Unity Cancer Center at Mercy and Unity Hospitals, Fridley, Minnesota, United States

Virginia Piper Cancer Institute at Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States

CentraCare Clinic - River Campus, St. Cloud, Minnesota, United States

Park Nicollet Clinic, St. Louis Park, Minnesota, United States

United Hospital, St. Paul, Minnesota, United States

Ridgeview Medical Center, Waconia, Minnesota, United States

Rice Memorial Hospital, Willmar, Minnesota, United States

CCOP - Montana Cancer Consortium, Billings, Montana, United States

Great Falls Clinic, Great Falls, Montana, United States

Sletten Regional Cancer Institute, Great Falls, Montana, United States

Fremont Area Medical Center, Fremont, Nebraska, United States

Bryan LGH Medical Center West, Lincoln, Nebraska, United States

Cancer Resource Center - Lincoln, Lincoln, Nebraska, United States

St. Elizabeth Regional Medical Center, Lincoln, Nebraska, United States

CCOP - Missouri Valley Cancer Consortium, Omaha, Nebraska, United States

Immanuel Medical Center, Omaha, Nebraska, United States

Bergan Mercy Medical Center, Omaha, Nebraska, United States

Cancer Center at Creighton University Medical Center, Omaha, Nebraska, United States

Midlands Cancer Center at Midlands Community Hospital, Papillion, Nebraska, United States

Rutherford Hospital, Rutherfordton, North Carolina, United States

Bismarck Cancer Center, Bismarck, North Dakota, United States

Medcenter One Health System, Bismarck, North Dakota, United States

Mid Dakota Clinic, P.C., Bismarck, North Dakota, United States

St. Alexius Medical Center, Bismarck, North Dakota, United States

Altru Cancer Center at Altru Hospital, Grand Forks, North Dakota, United States

Natalie Warren Bryant Cancer Center at St. Francis Hospital, Tulsa, Oklahoma, United States

Geisinger Medical Center, Danville, Pennsylvania, United States

Geisinger Medical Group, State College, Pennsylvania, United States

Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States

Rose Ramer Cancer Clinic at Anderson Area Medical Center, Anderson, South Carolina, United States

Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, United States

CCOP - Upstate Carolina, Spartanburg, South Carolina, United States

Sioux Valley Hospital and University of South Dakota Medical Center, Sioux Falls, South Dakota, United States

Avera McKennan Hospital and University Health Center, Sioux Falls, South Dakota, United States

Medical X-Ray Center, Sioux Falls, South Dakota, United States

Pasqua Hospital, Regina, Saskatchewan, Canada

Allan Blair Cancer Centre at Pasqua Hospital, Regina, Saskatchewan, Canada

Contact Details

Name: Charles L. Loprinzi, MD

Affiliation: Mayo Clinic

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: